CDLX - Company ID 0001666071
Cardlytics, Inc. trades as CDLX. In its fiscal 2025 annual report the company posted revenue of $233.27M, down 16.2% from the prior year and net income of -$104.00M. This page tracks Cardlytics, Inc. through 1,000 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Cardlytics, Inc.'s revenue grew from $112.82M to $233.27M, a compound annual growth rate of 8.4%. Net profit margin expanded from -67.1% to -44.6% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-20 |
| Insider trade | 4 | 2026-05-19 |
The largest companies sharing Cardlytics, Inc.'s SEC industry classification (services-computer programming, data processing, etc.).
Cardlytics, Inc. reported revenue of $233.27M for fiscal year 2025, a decrease of 16.2% year over year.
In its latest fiscal year Cardlytics, Inc. reported a net loss of $104.00M.